In spite of recognizing that Facebook's (NASDAQ: FB ) initial public offering would probably be one of the largest in history, "a design limitation in Nasdaq's system to match IPO buy and sell orders caused disruptions," resulting in significant disruptions to the IPO, according to a statement today from the SEC.
As a result of its "rules violations," Nasdaq has agreed to settle the dispute for a record $10 million, the largest fine ever reached with an exchange, according to the SEC. In the statement, the SEC said that exchanges "have an obligation to ensure that their systems, processes, and contingency planning are robust and adequate to manage an IPO without disruption to the market."
According to the SEC, after holding a "Code Blue" meeting before the Facebook IPO, Nasdaq executives concluded that they had isolated and fixed the "system limitation" and opted to move forward with the IPO. Doing so without understanding the basis of the problem resulted in multiple rules violations, according to the SEC, including the price/time priority for executing trades. The upshot of the system's shortcomings was that more than 30,000 Facebook trade orders were stuck for as long as two hours before being executed. The SEC noted additional violations as well, including the use of an unauthorized error account to short Facebook stock.
5 Best Managed Healthcare Stocks To Invest In 2015: Primco Management Inc (PMCM)
Primco Management Inc., incorporated on October 14, 2010, is a development-stage company. The Company focuses on offering estate management services for its clients and retention on a range of properties including class A office space, industrial, manufacturing, and warehousing facilities as well as data centers and retail outlets for real estate users. In addition, it also focuses on offering consulting services, including site selection, feasibility studies, exit strategies, market forecasts, strategic planning, and research services. In February 2013, the Company announced that ESMG, Inc. took controlling interest in the Company through the acquisition of more than 80% interest of the Company. In February 2013, it purchased the music catalog of D&B Music. In May 2013, the Company acquired Top Sail Productions.
As of December 31, 2010, the Company did not have any operations. During the year ended December 31, 2010, it did not generate any revenues.
Advisors' Opinion:- [By Peter Graham]
The marijuana field keeps sprouting small cap marijuana stocks like Primco Management Inc (OTCBB: PMCM), Medifirst Solutions Inc (OTCMKTS: MFST) and Modern Mobility Aids, Inc (OTCMKTS: MDRM) which are all trying to seek a high by playing up their connections (no matter how tenuous�� to what many consider to be the next high flying sector. But are these small cap marijuana stocks just blowing smoke at investors? Here is a quick reality check:
Top Heal Care Stocks To Own For 2014: Thor Industries Inc.(THO)
Thor Industries, Inc., together with its subsidiaries, manufactures and sells a range of recreation vehicles and small and mid-size buses, as well as related parts and accessories in the United States and Canada. The company offers a range of travel trailers and motorhomes under the trade name of Airstream, which include Airstream Safari, International, Flying Cloud, and Bambi travel trailers, as well as Interstate Class B motorhomes. It also manufactures and sells conventional travel trailers and fifth wheels under the trade names of Dutchmen, Four Winds, Aero, Grand Junction, Colorado, Cruiser, Seville, Zinger, and Sunset Trail; travel trailers and fifth wheels under trade names of Montana, Springdale, Hornet, Sprinter, Outback, Laredo, Everest, Mountaineer, Challenger, Cougar, Komfort, and Trailblazer; and gasoline and diesel Class C, Class A, and Class B motorhomes under the trade names of Four Winds, Hurricane, Windsport, Mandalay, Dutchmen, Chateau, Serrano, Ventura, and Fun Mover. In addition, it manufactures and sells gasoline and diesel Class A motor homes under the trade names of Daybreak, Challenger, Astoria, Tuscany, Outlaw, and Avanti; travel trailers, fifth wheels, truck campers, and park models under the trade name of General Coach; and park models under the trade names of Tranquility, Westchester, and Breckenridge. Further, the company manufactures small and mid-size transit and commercial buses under the trade names of Aerolite, AeroElite, Aerotech, Escort, MST, Transmark, EZ Rider, Axess, Challenger, Defender, Crusader, American Cruiser, Classic Coach, EZ Trans, GC II, and Pacer. It markets its vehicles through independent dealers to municipalities and private purchasers, such as rental car companies and hotels. The company has a joint venture agreement with Cruise America, Inc. to provide short-term rentals of motorized recreation vehicles to the public. Thor Industries was founded in 1980 and is based in Jackson Center, Oh io.
Advisors' Opinion:- [By John Udovich]
The CEO of recreation vehicle (RV) stock Winnebago Industries, Inc (NYSE: WGO) recently appeared on CNBC to say that the economy is improving for RV makers, meaning its time to take a closer look at the stock plus take a look at the performance of other small cap RV stocks like Drew Industries, Inc (NYSE: DW), Skyline Corporation (NYSEMKT: SKY) and Thor Industries, Inc (NYSE: THO).
- [By Grace L. Williams]
Shares of Winnebago have gained 4.4% to $28.47 today at 3pm. Thor Industries (THO), which also makes recreational vehicles, has ticked up 0.1% to $57.56, Drew Industries (DW) has risen 0.3% to $48.74, Arctic Cat (ACAT) has advanced 1% to $59.87 and Polaris Industries (PII) has fallen 0.3% to $132.08.
- [By Rich Smith]
Thor Industries (NYSE: THO ) has a new CEO.
On Monday, the Elkhart, Ind.-based RV manufacturer announced it has promoted current President and Chief Operating Officer Bob Martin to the position of CEO. The appointment will become effective on August 1, when current CEO Peter B. Orthwein gives up his post (but remains executive chairman of the board of directors).
- [By Lauren Pollock]
Thor Industries Inc.'s(THO) fiscal first-quarter earnings rose 33% on the strength of higher sales and wider margins. But results came in lower than expected.
Top Heal Care Stocks To Own For 2014: Cedar Shopping Centers Inc (CDR)
Cedar Shopping Centers, Inc., real estate investment trust, engages in the ownership, operation, development and redevelopment of supermarket-anchored community shopping centers and drug store-anchored convenience centers in the United States. As of December 31, 2007, it owned 118 properties, aggregating approximately 12.0 million square feet of gross leasable area primarily in Pennsylvania, Massachusetts, Virginia, Ohio, Connecticut, New Jersey, Maryland, Michigan, and New York. Cedar Shopping has elected to be treated as a REIT for federal income tax purposes and would not be subject to federal income tax, if it distributes at least 90% of its REIT taxable income to its stockholders. The company was founded in 1984 and is based in Port Washington, New York.
Advisors' Opinion:- [By Bill Smith]
Valuation
Lastly, because of the negative perception the entire industry has received, prices in this sector have been absolutely pummeled. ESI now trades at the lower end of all of its historical valuation bands: P/E, P/B, and P/S.
Bullish Points
Guru ownership and avg price: ESI owned by Hussman ($76.15), Weitz ($75.32), and Greenblatt ($73.29)Over 35% of shares are short, potential short squeezeStock buyback plan: ESI reduced outstanding shares by 19% yoy at the end of the 4th quarter. They repurchased 370K shares in 3Q11.The business model is scalable; the incremental cost to educate each additional student is low, leading to high marginsESI acquired Daniel Webster College, giving them a regional accreditation which they can use to broaden their reach in online classes
Bearish Points
High costs of education, in general, rightly or wrongly attract government intervention and could squeeze margins over time. Total student debt surpassed credit card balances, and sits at $1 Trillion as of the end of 2011.Subject to compliance with Dept of Education's 90/10 rules, which states a college can't collect more than 90% of revenue from students participating in federal loan programs.Cohort Default Rate (CDR): for-profit colleges must monitor the federal loan default rates of students who graduate or leave the school. If a school's CDR exceeds 25% for 3 consecutive years, or 40% in any one year, its students won't be eligible for federal financial aid.ESI competes on quality of product which is measured by graduation rates and ability to secure employment. For 2010, 70% of ESI graduates got employment in positions using skills taught in their program of study within 1 year. As of Oct 2011, this rate was 600 bp higher. The average annual salary reported by employed 2011 grads was $32K, compared to $32.4K for 2010 grads.With an improving economy, there's a potential ESI would see declining new student enrollmentsOver 35% of shares are short
Summary
Top Heal Care Stocks To Own For 2014: NovaBay Pharmaceuticals Inc. (NBY)
NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the development of various product candidates for the therapeutic needs of the anti-infective market. Its products include Aganocide compounds comprising NVC-422 that are synthetic molecules for the treatment of impetigo and adenoviral conjunctivitis, as well as for reducing the incidence of urinary catheter blockage and encrustation, and the associated urinary tract infections. The company is also involved in developing NeutroPhase, a solution for cleansing and debriding wounds. It has collaboration and license agreement with Galderma S.A. to develop and commercialize its Aganocide compounds, which covers acne, impetigo, and other dermatological conditions. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
Advisors' Opinion:- [By CRWE]
NovaBay(r) Pharmaceuticals, Inc. (Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide(r) compounds for the local non-systemic treatment and prevention of infections, reported that Tom Paulson, Chief Financial Officer, will present at the Rodman & Renshaw 14th Annual Healthcare Conference held September 9-11, 2012, in New York, NY.
Top Heal Care Stocks To Own For 2014: Rigel Pharmaceuticals Inc.(RIGL)
Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.
Advisors' Opinion:- [By Maxx Chatsko]
Rigel Pharmaceuticals (NASDAQ: RIGL ) was kicked in the stomach earlier this month, when AstraZeneca (NYSE: AZN ) returned full rights for fostamatinib. The Big Pharma member decided to write off $140 million of assets attributed to the partnership rather than take the next steps in commercializing the drug for rheumatoid arthritis. Ouch. While it's a smart idea for AstraZeneca to walk away now, Rigel is in a tough spot with its top drug candidate receiving a vote of no confidence. There is a handful of companies that stand to benefit from fostamatinib's failure. In the following video, Fool contributor Maxx Chatsko explains what it means for investors and what the future could hold for the development-stage company. �
- [By Sean Williams]
What: Shares of Rigel Pharmaceuticals (NASDAQ: RIGL ) , a clinical-stage small molecule drug company focused on inflammatory and autoimmune disorders, dropped as much as 21% after the company resumed full responsibility for its rheumatoid arthritis pill, Fostamatinib, and reported topline data from two late-stage studies involving the drug.
Top Heal Care Stocks To Own For 2014: Integrated Device Technology Inc. (IDTI)
Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of integrated circuits for communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer. The Communications segment offers communication clocks, digital logic products, first in and first out memories, serial RapidIO solutions for wireless base station infrastructure applications, integrated communications processors, static random access memory products, radio frequency products, and telecommunications semiconductor products. This segment markets its products to the enterprise, data center, and wireless markets. The Computing and Consumer segment provides timing products, PCI Express switching and bridging solutions, high-performance server memory interfaces, multi-port products, touch controllers, signal integrity products, and PC audio and video products. This segment?s computing products are designed for deskto p, notebook, sub-notebook, storage, and server applications; and consumer products are optimized primarily for gaming consoles, set-top boxes, digital TV, and smart phones. The company markets its products primarily to original equipment manufacturers through various channels, including a direct sales force, distributors, electronic manufacturing suppliers, and independent sales representatives. Integrated Device Technology, Inc. was founded in 1980 and is headquartered in San Jose, California.
Advisors' Opinion:- [By Garrett Cook]
Integrated Device Technology (NASDAQ: IDTI) shares were also up, gaining 19.09 percent to $16.72 after the company reported better-than-expected quarterly earnings.
- [By Garrett Cook]
Integrated Device Technology (NASDAQ: IDTI) shares were also up, gaining 18.80 percent to $16.68 after the company reported better-than-expected quarterly earnings.
Top Heal Care Stocks To Own For 2014: Oxford Resource Partners LP(OXF)
Oxford Resource Partners, LP, together with its subsidiaries, engages in the production of steam coal and surface mined coal in the United States. It holds interests in approximately 21 active surface mines that are managed as 8 mining complexes located in Northern Appalachia and the Illinois Basin to serve its primary market area of Illinois, Indiana, Kentucky, Ohio, Pennsylvania, and West Virginia. The company sells its coal primarily to utilities with coal-fired, base-load scrubbed power plants under long-term coal sales contracts, as well as to municipalities, cooperatives, and industrial customers. Oxford Resource Partners, LP was founded in 1985 and is based in Columbus, Ohio.
Advisors' Opinion:- [By Robert Rapier]
The worst performer in the first half was�Oxford Resource Partners�(NYSE: OXF), a coal producer that suspended its distribution more than a year ago and has seen its unit price continue to decline. It is down 31.5 percent in 2014.�Boardwalk Pipeline Partners�(NYSE: BWP) saw the second worst decline in the first half of 2014 after announcing a distribution cut of more than 80 percent. BWP saw its unit price plunge by 46 percent in a single trading session. It has since recovered somewhat, but is down 28.8 percent year-to-date.
- [By Robert Rapier]
There are a few US coal MLPs, many of which have seen their market caps decimated in the past 2 ½ years. Most MLP investors should avoid this sector, as more restrictive EPA regulations and competition from natural gas and renewables will continue to put pressure on coal producers. For bargain hunters who are prepared for the possibility of further downside, there are one or two that have strong balance sheets. But don’t go bargain hunting just on the basis of price. Remember that the worst-performing of all MLPs in 2013 was coal producer Oxford Resource Partners (NYSE: OXF) — down 73 percent for the year and illustrative of the coal industry’s struggles.
- [By Robert Rapier]
1. Oxford Resource Partners
The coal industry in the US has been badly battered over the past few years. Oxford Resource Partners (NYSE: OXF) was a casualty, as the unit price fell 73 percent in 2013. The biggest problem for this producer of coal in the northern Appalachia and the Illinois Basin was that it had to suspend cash distributions in January in response to continued weakness in the coal markets.
2. Rentech Nitrogen Partners
- [By Robert Rapier]
The National Association of Publicly Traded Partnerships (NAPTP) lists five MLPs in the category ��atural Resources – Coal,��although two of the five are Alliance Holdings (NYSE: AHGP) and its operating affiliate, Alliance Resource Partners (NYSE: ARLP). The other three are Natural Resource Partners (NYSE: NRP), Rhino Resource Partners (NYSE: RNO), and Oxford Resource Partners (NYSE: OXF).
No comments:
Post a Comment